| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |